Navigation Links
Fujifilm Launches Ultrasound Product Line in U.S.
Date:8/15/2011

GRAPEVINE, Texas, Aug. 15, 2011 /PRNewswire/ -- Today at the 2011 AHRA FUJIFILM Medical Systems U.S.A., Inc. announced the company's entry into the portable ultrasound market with the commercial availability of the Fazone CB®. Designed to meet the needs of the point-of-care and mobile healthcare environments, the Fazone CB is a compact and lightweight unit that produces high quality images quickly and easily for on-the-go clinicians.

"The Fazone CB is an ideal option for healthcare professionals when fast, high quality imaging from a portable device is required," says Janine Rader, Fujifilm's VP Business Development for Ultrasound.  "Whether it be at a patient's bedside or in an environment where mobility is needed such as a crowded operating room or the emergency room – where every second counts – the Fazone CB is small in size, but big on function and results."

The Fazone CB features Zone Sonography™*, a technology that employs complex signal processing unlike other conventional ultrasound systems.  Zone Sonography™ acquires ultrasound data ten times faster**, resulting in less motion artifacts delivering image uniformity at every point.  

Other highlights of the Fazone CB include:

  • One-touch image optimization
  • Ready to use within seconds
  • On-board USB, HDMI and Ethernet ports allow for simple connectivity anywhere
  • All management tools are available in the system, including DICOM store, print, MWLM and MPPS
  • Optional fully adjustable and extremely maneuverable cart provides the capabilities of a traditional cart-based system, including multiple transducer connectors
  • Optional full-size keyboard
  • Multiple documentation options to choose from
  • Large 12" monitor for easy viewing

In Japan, the Fazone CB won the 2010 GOOD DESIGN™ Award, an award that bestows international recognition upo
'/>"/>

SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Now Approved: Fujifilms FDR AcSelerate Direct Digital DR System
2. FUJIFILM Enters Advanced Visualization Market
3. FUJIFILM Establishes Medical Informatics Organization
4. FUJIFILMs DR-based FFDM System Makes US Debut at RSNA
5. FUJIFILMs DR Cassette Makes World Debut
6. FUJIFILM Europe Teams Synapse with Matrox Xenia
7. Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation
8. Fujitani Takes the Helm at FUJIFILM Medical Systems U.S.A.
9. FUJIFILMs FDR D-EVO™ is Now Available and Shipping
10. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
11. Fujifilms Synapse® Mobility Extends Imaging Reach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 Investor-Edge has initiated ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ), ... (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... be accessed at: http://investor-edge.com/register . On Tuesday, ... 0.07%, the Dow Jones Industrial Average edged 0.02% lower, to ...
(Date:11/26/2014)... A hernia is condition in which ... the wall of a weak muscle area. Obesity, poor nutrition, ... of the causes of hernias. There are several types of ... inguinal hernia is when part of the abdominal tissue/organ protrudes ... the area of the umbilicus. A hiatal hernia is when ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Aridis ... to produce novel therapies for infectious diseases, announced ... M.D., an internationally recognized key opinion leader in ... Company,s scientific advisory board. Founder and ... stated, "We believe Dr. Opal,s extensive experience investigating ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... a leading developer of innovative catheters and stents for ... closing of a $17M Round D financing.  The financing ... based EDB Investments (,EDBI,) with strong support from current ... are delighted to have Bio*One join our group of ...
... Arable Corporation ( www.arablecorp.com ) has announced the launch ... the clinical trial industry.  Whereas traditional CTMS systems have ... CTMS and EDC capabilities without the traditionally high start-up ... or CROs to manage the planning and implementation of ...
Cached Medicine Technology:TriReme Medical Announces $17 Million Series D Financing 2Arable Corporation Announces New Technology for Clinical Trial Industry 2
(Date:11/27/2014)... November 27, 2014 Now that Thanksgiving ... has officially launched, Emassagechair.com has announced its ... Discount Event. , Negotiating on behalf of their ... massage chair brands, Emassagechair.com has generated significant buzz in ... and biggest discounts yet. , Shoppers are excited for ...
(Date:11/27/2014)... 2014 VogueQueen.com is making every effort ... across the world. As the premier online supplier of ... proud to release a huge selection of sexy prom ... it is also providing many beautiful styles in its ... at discounted prices. , “VogueQueen.com hopes to provide ...
(Date:11/27/2014)... Viejo, California (PRWEB) November 27, 2014 Developers ... announced a new plugin entitled ProPip, taking FCPX to the ... in picture effect with a few clicks of a mouse,” ... a time saver that our users will appreciate.” , With ... full customization leaving the possibilities truly endless. ProPip is great ...
(Date:11/27/2014)... 27, 2014 HealthPostures, a ... equipment , has announced that it has entered ... Environments. The partnership will put HealthPostures' products into ... , In addition to having its products sold ... promotes HealthPostures' products with the business decision makers ...
(Date:11/27/2014)... November 27, 2014 At The Little ... So it came as no surprise when a recent ... child’s academic success. The Journal of Pediatrics ... and motor tasks during the school years may be ... academic development.” The study monitored two groups of children; ...
Breaking Medicine News(10 mins):Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... Care at the 15th SPSSCS Annual Meeting , ... New York, NY ... Specialists (SPSSCS) celebrates its 15th Annual Meeting - Play the Winning Hand: ... Vegas, NV. The meeting offers educational seminars for nurses, aestheticians ...
... Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR ... in Mexico and operator of Cancun Airport and eight others ... 26, 2009 the Mexican Secretary of Health confirmed the presence ... 28, 2009 the World Health Organization (the "WHO") acknowledged the ...
... Executive Chairman & CEO Douglas MacLellan offers expert insight ... April 29 AMDL Inc. ... major operations in China, announced today its Executive Chairman ... featured in The Wall Street Transcript - ...
... 23 June 2009, the Prostate Cancer Translational Research ... the Beurs van Berlage in Amsterdam (NL). Translational ... or population studies into clinical applications to reduce ... Association of Urology (EAU) provides an excellent forum ...
... Sales & Marketing Data In One Screen To ... Custom Metrics EWING, N.J., April 29 Archi-Tech ... reporting solutions, today announced the availability of managed ... portal for pharmaceutical sales reporting. Using InView, managed ...
... New analyses of data from the 16-Year ... by Bayer HealthCare Pharmaceuticals, were presented at the ... The study results showed that early and ... multiple sclerosis (MS) were more likely to avoid ...
Cached Medicine News:Health News:Play the Winning Hand - Watching Your Fortunes Grow in Skin Care 2Health News:Play the Winning Hand - Watching Your Fortunes Grow in Skin Care 3Health News:Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets 2Health News:Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets 3Health News:EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results 2Health News:Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 3Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 4